Advisor Group Inc. increased its stake in shares of Petmed Express Inc (NASDAQ:PETS) by 11.9% during the 4th quarter, Holdings Channel reports. The firm owned 46,086 shares of the company’s stock after acquiring an additional 4,909 shares during the quarter. Advisor Group Inc.’s holdings in Petmed Express were worth $2,097,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in PETS. Sei Investments Co. boosted its stake in Petmed Express by 50,142.9% in the third quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock valued at $117,000 after acquiring an additional 3,510 shares during the last quarter. LS Investment Advisors LLC boosted its stake in Petmed Express by 283.5% in the fourth quarter. LS Investment Advisors LLC now owns 2,861 shares of the company’s stock valued at $130,000 after acquiring an additional 2,115 shares during the last quarter. Sterling Investment Advisors Ltd. boosted its stake in Petmed Express by 118.5% in the fourth quarter. Sterling Investment Advisors Ltd. now owns 2,950 shares of the company’s stock valued at $134,000 after acquiring an additional 1,600 shares during the last quarter. Thompson Siegel & Walmsley LLC bought a new position in Petmed Express in the third quarter valued at approximately $149,000. Finally, CenterStar Asset Management LLC bought a new position in Petmed Express in the fourth quarter valued at approximately $169,000. 91.30% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have issued reports on PETS shares. ValuEngine raised shares of Petmed Express from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. BidaskClub cut shares of Petmed Express from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 19th. Finally, Northcoast Research set a $58.00 price objective on shares of Petmed Express and gave the company a “buy” rating in a research note on Wednesday, January 3rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. Petmed Express has an average rating of “Hold” and an average price target of $42.80.
In other news, CEO Menderes Akdag sold 30,000 shares of Petmed Express stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $51.00, for a total transaction of $1,530,000.00. Following the transaction, the chief executive officer now directly owns 490,000 shares of the company’s stock, valued at $24,990,000. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Ronald J. Korn sold 5,000 shares of Petmed Express stock in a transaction on Monday, January 29th. The stock was sold at an average price of $48.38, for a total transaction of $241,900.00. Following the transaction, the director now directly owns 68,833 shares in the company, valued at $3,330,140.54. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,000 shares of company stock worth $2,341,900. Insiders own 4.00% of the company’s stock.
Petmed Express Inc (NASDAQ PETS) opened at $43.27 on Friday. The firm has a market cap of $951.77, a price-to-earnings ratio of 25.60, a PEG ratio of 2.61 and a beta of 0.93. Petmed Express Inc has a 52-week low of $19.80 and a 52-week high of $57.80.
Petmed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, January 22nd. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. The company had revenue of $60.10 million for the quarter, compared to analysts’ expectations of $56.76 million. Petmed Express had a net margin of 12.84% and a return on equity of 34.04%. The business’s quarterly revenue was up 13.6% compared to the same quarter last year. During the same period last year, the firm posted $0.24 earnings per share. equities analysts anticipate that Petmed Express Inc will post 1.77 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, February 16th. Stockholders of record on Monday, February 5th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.31%. This is a boost from Petmed Express’s previous quarterly dividend of $0.20. The ex-dividend date was Friday, February 2nd. Petmed Express’s dividend payout ratio (DPR) is currently 59.17%.
TRADEMARK VIOLATION NOTICE: “Petmed Express Inc (PETS) Shares Bought by Advisor Group Inc.” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/03/18/petmed-express-inc-pets-shares-bought-by-advisor-group-inc.html.
Petmed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.